Larimar Therapeutics Files 8-K Report
Ticker: LRMR · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1374690
| Field | Detail |
|---|---|
| Company | Larimar Therapeutics, Inc. (LRMR) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, material-event
TL;DR
Larimar Therapeutics filed an 8-K on 7/29/25, indicating a significant event.
AI Summary
On July 29, 2025, Larimar Therapeutics, Inc. filed an 8-K report. The filing indicates a change in the company's status or operations, though specific details regarding results of operations or financial condition are not elaborated upon in the provided text. The company, formerly known as Zafgen, Inc., is incorporated in Delaware and headquartered in Bala Cynwyd, Pennsylvania.
Why It Matters
This 8-K filing signals a material event or change for Larimar Therapeutics, Inc., requiring disclosure to investors and the public.
Risk Assessment
Risk Level: medium — An 8-K filing indicates a material event, which could be positive or negative, thus carrying medium risk until details are understood.
Key Numbers
- 001-36510 — Commission File Number (Identifies the company's SEC filing history)
- 20-3857670 — I.R.S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Larimar Therapeutics, Inc. (company) — Registrant
- Zafgen, Inc. (company) — Former company name
- July 29, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Bala Cynwyd, Pennsylvania (location) — Principal executive offices
FAQ
What specific event triggered this 8-K filing by Larimar Therapeutics, Inc. on July 29, 2025?
The provided text states the filing is for 'Results of Operations and Financial Condition' but does not specify the exact event. Further details would be in the full report.
What was Larimar Therapeutics, Inc. formerly known as?
Larimar Therapeutics, Inc. was formerly known as Zafgen, Inc.
In which state is Larimar Therapeutics, Inc. incorporated?
Larimar Therapeutics, Inc. is incorporated in Delaware.
Where are Larimar Therapeutics, Inc.'s principal executive offices located?
Larimar Therapeutics, Inc.'s principal executive offices are located at Three Bala Plaza East, Suite 506, Bala Cynwyd, Pennsylvania, 19004.
What is the telephone number for Larimar Therapeutics, Inc. as listed in the filing?
The telephone number for Larimar Therapeutics, Inc. is (844) 511-9056.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Larimar Therapeutics, Inc. (LRMR).